Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

IL-15 and TNF-α levels are higher in alopecia areata patients, especially in alopecia totalis.

17β-estradiol can reduce inflammation in the skin.

Dexamethasone reduces inflammation and delays skin cell changes caused by TPA.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

Discoid lupus erythematosus involves immune activation and fibrosis around hair follicles, with shared pathways across humans, dogs, and mice, suggesting potential treatments for both humans and animals.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

Bullous pemphigoid is influenced by genetic factors, immune cell dysfunction, aging, and triggers, with treatment often improving symptoms.

Higher levels of IL-1a and IL-1RA were found in severe alopecia areata cases.

Thymus-derived Tregs, not peripherally-derived Tregs, primarily regulate type 1 diabetes in the NOD mouse model.

Type XVII collagen may help prevent skin aging.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Type XVII collagen helps control skin cell growth and may have anti-aging effects.

DM and AA may share a common cause.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

The document concludes that reactivation of herpesviruses, especially HHV-6, is linked to severe symptoms and complications in drug-induced hypersensitivity syndrome.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Enhancing Tregs can protect against alopecia areata.

Type 2 immunity helps control mite growth in hair follicles, preventing damage.

Hair follicles help attract immune cells to minor skin injuries.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

More research is needed to understand and manage rheumatoid arthritis better.

Type 1 diabetes may cause certain autoimmune diseases in Europeans.

Alopecia areata involves complex immune activity, mainly Th1, with potential benefits from broader immune treatments.

Targeting IL-17 could help treat pattern hair loss.

IL-19 and IL-24 help cells respond to DNA damage and could be targeted for cancer and age-related disease treatments.

PRO-C22 can help diagnose and monitor the severity of hidradenitis suppurativa.

Autoimmune reactions may cause both alopecia areata and HAM.